pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    ENB-003
    Pancreatic Cancer ENB Therapeutics LLC
  • Phase 2
    EO-2463
    Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat… Enterome Bioscience SA
  • Phase 2
    EPI-321
    Facioscapulohumeral Muscular Dystrophy (FSHD) Epicrispr Biotechnologies Inc
  • Phase 2
← prev
page 12 of 53
next →
131
Pain89
Neurology1
EPINEPHRINE
EPINEPHRINE
1 INDICATIONS AND USAGE Epinephrine is a non-selective al…
$AMRX Amneal Pharmaceuticals, Inc.
  • Phase 2
    ERC-1671
    Gliovac
    Gliosarcoma ERC Belgium SA
  • Phase 2
    ET-1402
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 2
    ETD-001
    Cystic Fibrosis Enterprise Therapeutics Ltd
  • Phase 2
    ETX-101
    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Encoded Therapeutics Inc
  • Phase 2
    ETX-19477
    Ovarian Cancer 858 Therapeutics Inc
  • Phase 2
    ETX-636
    Human Epidermal Growth Factor Receptor 2 Negative Breast… ENSEM Therapeutics Inc
  • Phase 2
    EU-101
    Colorectal Cancer Eutilex Co Ltd
  • Phase 2
    EVM-14
    Esophageal Squamous Cell Carcinoma (ESCC) Everest Medicines Ltd
  • Phase 2
    EVO-756
    Chronic Inducible Urticaria$EVMN Evommune, Inc.
  • Phase 2
    EVX-01
    Metastatic Melanoma$EVAX Evaxion A/S
  • Phase 2
    EXE-346
    Pouchitis ExeGi Pharma LLC
  • Phase 2
    EXG-34217
    Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome) Elixirgen Therapeutics Inc
  • Phase 2
    EXT-608
    Hypoparathyroidism Extend Biosciences Inc
  • Phase 2
    EcoActive
    Crohn's Disease (Regional Enteritis) Ferring International Center SA
  • Phase 2
    Elixcyte
    Elixcyte
    Chronic Kidney Disease (Chronic Renal Failure) Unicocell Biomed Co Ltd
  • Phase 2
    F-652
    Alcoholic Hepatitis Evive Biotech
  • Phase 2
    FB-102
    Celiac Disease$FBRX Forte Biosciences, Inc.
  • Phase 2
    FB-825
    Atopic Dermatitis (Atopic Eczema) Oneness Biotech Co Ltd
  • Phase 2
    FB-849
    Solid Tumor 1st Bio Therapeutics Inc
  • Phase 2
    FF-10502-01
    Solid Tumor Fujifilm Holdings Corp
  • Phase 2
    FGF-1
    Coronary Artery Disease (CAD) (Ischemic Heart Disease) Zhittya Genesis Medicine Inc
  • Phase 2
    FKPC-101
    Metastatic Prostate Cancer CellVax Therapeutics Inc
  • Phase 2
    FP-101
    Vasomotor Symptoms of Menopause (Hot Flashes) Fervent Pharmaceuticals LLC
  • Phase 2
    FPI-2265
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Fusion Pharmaceuticals Inc
  • Phase 2
    FWD-1802
    Metastatic Breast Cancer Shenzhen Forward Pharmaceutical Co Ltd
  • Phase 2
    Fancalen
    Fanconi Anemia Centers of Biomedical Research Network